DK165696C - Desulfatohirudiner og deres farmaceutisk acceptable salte, deres fremstilling, farmaceutisk praeparat indeholdende disse forbindelser og anvendelse af forbindelserne til fremstilling af farmaceutisk middel og som analytisk reagens - Google Patents

Desulfatohirudiner og deres farmaceutisk acceptable salte, deres fremstilling, farmaceutisk praeparat indeholdende disse forbindelser og anvendelse af forbindelserne til fremstilling af farmaceutisk middel og som analytisk reagens

Info

Publication number: DK165696C
Authority: DK; Denmark
Prior art keywords: preparation; pharmaceutical; hirudines; desulphato; analytics
Prior art date: 1983-11-22

Application number

DK552684A

Other languages

Danish (da)

English (en)

Other versions

DK552684A (da

DK552684D0 (da

DK165696B (da

Inventor

Hans Fritz

Johannes Dodt

Ursula Seemueller

Ernst Fink

Original Assignee

Ciba Geigy Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-11-22

Filing date

1984-11-21

Publication date

1993-05-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6214920&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK165696(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1984-11-21 Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag

1984-11-21 Publication of DK552684D0 publication Critical patent/DK552684D0/da

1985-05-23 Publication of DK552684A publication Critical patent/DK552684A/da

1993-01-04 Publication of DK165696B publication Critical patent/DK165696B/da

1993-05-24 Application granted granted Critical

1993-05-24 Publication of DK165696C publication Critical patent/DK165696C/da

Links

239000008177 pharmaceutical agent Substances 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
150000003839 salts Chemical class 0.000 title 1
102000007625 Hirudins Human genes 0.000 abstract 1
108010007267 Hirudins Proteins 0.000 abstract 1
230000004071 biological effect Effects 0.000 abstract 1
230000023555 blood coagulation Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 abstract 1
229940006607 hirudin Drugs 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Tropical Medicine & Parasitology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Hematology (AREA)
Diabetes (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Investigating Or Analysing Biological Materials (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK552684A 1983-11-22 1984-11-21 Desulfatohirudiner og deres farmaceutisk acceptable salte, deres fremstilling, farmaceutisk praeparat indeholdende disse forbindelser og anvendelse af forbindelserne til fremstilling af farmaceutisk middel og som analytisk reagens DK165696C (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19833342139 DE3342139A1 (de)	1983-11-22	1983-11-22	Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
DE3342139		1983-11-22

Publications (4)

Publication Number	Publication Date
DK552684D0 DK552684D0 (da)	1984-11-21
DK552684A DK552684A (da)	1985-05-23
DK165696B DK165696B (da)	1993-01-04
DK165696C true DK165696C (da)	1993-05-24

Family

ID=6214920

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK552684A DK165696C (da)	1983-11-22	1984-11-21	Desulfatohirudiner og deres farmaceutisk acceptable salte, deres fremstilling, farmaceutisk praeparat indeholdende disse forbindelser og anvendelse af forbindelserne til fremstilling af farmaceutisk middel og som analytisk reagens

Country Status (19)

Country	Link
US (3)	US4654302A (fr)
EP (1)	EP0142860B1 (fr)
JP (1)	JP2551551B2 (fr)
AT (1)	ATE56021T1 (fr)
AU (1)	AU578050B2 (fr)
CA (1)	CA1239606A (fr)
CY (1)	CY1737A (fr)
DD (1)	DD232498A5 (fr)
DE (3)	DE3342139A1 (fr)
DK (1)	DK165696C (fr)
HK (1)	HK121293A (fr)
IE (1)	IE57885B1 (fr)
IL (1)	IL73570A (fr)
LU (1)	LU90192I2 (fr)
MX (1)	MX9203370A (fr)
NL (1)	NL970045I2 (fr)
NZ (1)	NZ210275A (fr)
PH (1)	PH23831A (fr)
ZA (1)	ZA849068B (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3342139A1 (de) *	1983-11-22	1985-05-30	Ciba-Geigy Ag, Basel	Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
FR2562088B1 (fr) *	1984-03-27	1987-11-13	Transgene Sa	Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
US5705355A (en) *	1984-03-27	1998-01-06	Transgene, S.A.	Hirudin, pharmaceutical compositions comprising it and their use
DE3438296A1 (de) *	1984-04-18	1985-11-07	Hoechst Ag, 6230 Frankfurt	Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel
ATE64956T1 (de) *	1984-06-14	1991-07-15	Ciba Geigy Ag	Verfahren zur herstellung von thrombininhibitoren.
DE3429430A1 (de) *	1984-08-10	1986-02-20	Hoechst Ag, 6230 Frankfurt	Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens
DE3445532A1 (de) *	1984-12-13	1986-06-19	Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn	Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
DE3506992A1 (de) *	1985-02-27	1986-08-28	Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn	Modifizierte hirudine, verfahren zu deren herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
JPS6229997A (ja) *	1985-04-08	1987-02-07	Sankyo Co Ltd	Ｃ末端にプロリンアミドを有するペプチドの製法
DE3738541A1 (de) *	1987-11-13	1989-05-24	Hoechst Ag	Verfahren zur isolierung und reinigung von hirudin
EP0209061B1 (fr) *	1985-07-17	1994-01-12	Hoechst Aktiengesellschaft	Peptides à activité anticoagulante, leur procédé de préparation, d'obtention, leur application et les agents les contenant
MY101203A (en) *	1985-12-12	1991-08-17	Ucp Gen Pharma Ag	Production of thrombin iinhibitors.
US6005071A (en) *	1987-01-23	1999-12-21	Merrell Pharmaceuticals Inc.	Anticoagulant peptides
US5789540A (en) *	1987-01-23	1998-08-04	Merrell Pharmaceuticals Inc.	Anticoagulant peptides
US5236898A (en) *	1987-05-21	1993-08-17	Merrell Dow Pharmaceuticals Inc.	Cyclic anticoagulant peptides
US5192745A (en) *	1987-05-21	1993-03-09	Merrell Dow Pharmaceuticals Inc.	Cyclic anticoagulant peptides
US5256559A (en) *	1988-03-04	1993-10-26	Biogen, Inc.	Methods and compositions for inhibiting platelet aggregation
AU3098289A (en) *	1988-03-04	1989-09-07	Biogen, Inc.	Hirudin peptides
AU614121B2 (en) *	1988-05-04	1991-08-22	Novartis Ag	Improvements in the production of polypeptides
US4971953A (en) *	1988-05-10	1990-11-20	Merrell Dow Pharmaceuticals	Anticoagulant peptide alcohols
DE58907266T2 (de) *	1988-06-11	1994-09-29	Ciba Geigy Ag	Polypeptide mit einer die Koagulierung hemmenden Wirkung.
US5268296A (en) *	1988-06-11	1993-12-07	Ciba-Geigy Corporation	DNA vector and recombinant host cell for production of hirullin P6 and P18
US5112615A (en) *	1988-08-03	1992-05-12	New England Deaconess Hospital Corporation	Soluble hirudin conjugates
US5167960A (en) *	1988-08-03	1992-12-01	New England Deaconess Hospital Corporation	Hirudin-coated biocompatible substance
GB8822147D0 (en) *	1988-09-21	1988-10-26	Ciba Geigy Ag	Pharmaceutically active combination
WO1990003391A1 (fr) *	1988-09-29	1990-04-05	Biogen, Inc.	Peptides d'hirudine
US4994367A (en) *	1988-10-07	1991-02-19	East Carolina University	Extended shelf life platelet preparations and process for preparing the same
DE3835815A1 (de) *	1988-10-21	1990-04-26	Hoechst Ag	Neue isohirudine
WO1990006128A1 (fr) *	1988-12-05	1990-06-14	Biogen, Inc.	Methodes et compositions pour inhiber l'agregation des plaquettes
US4861865A (en) *	1989-01-23	1989-08-29	Washington University	Novel antithrombin peptide
US5179196A (en) *	1989-05-04	1993-01-12	Sri International	Purification of proteins employing ctap-iii fusions
US6239101B1 (en) *	1989-07-05	2001-05-29	Oklahoma Medical Research Foundation	Thrombin binding polypeptides
US5192747A (en) *	1989-10-03	1993-03-09	Merrell Dow Pharmaceuticals Inc.	Anticoagulant peptides
CA2035917C (fr) *	1990-02-13	2001-10-02	John L. Krstenansky	Derives sulfonate, sulfate, phosphonate et phosphate stabilises de hirudine
US5118790A (en) *	1990-07-24	1992-06-02	Sri International	Analogs of hirudin
US5837808A (en) *	1991-08-20	1998-11-17	Baxter International Inc.	Analogs of hirudin
DE4209110A1 (de) *	1991-11-26	1993-05-27	Basf Ag	Neue thrombininhibitorische proteine aus landblutegeln
DE4140381A1 (de) *	1991-12-07	1993-06-09	Hoechst Ag, 6230 Frankfurt, De	Neue synthetische isohirudine mit verbesserter stabilitaet
GB9401447D0 (en)	1994-01-26	1994-03-23	Ciba Geigy Ag	Pharmaceutical compositions
DE4404168A1 (de) *	1994-02-10	1995-08-17	Hoechst Ag	Hirudinderivate und Verfahren zu deren Herstellung
DE19607239A1 (de)	1996-02-27	1997-08-28	Behringwerke Ag	Pharmazeutische Zusammensetzung, enthaltend Hirudin und Verfahren zu deren Herstellung
KR20000070338A (ko)	1997-01-20	2000-11-25	나가시마 카쭈시게, 노미야마 아키히코	펩티드의 안정화 방법 및 당해 방법을 이용한 펩티드 함유 동결건조 의약조성물
DE19755682A1 (de) *	1997-12-15	1999-06-17	Knoll Ag	Verfahren zur Ermittlung eines Dosierungschemas für Thrombininhibitoren
DE10149678A1 (de)	2001-10-09	2009-03-12	Novel Science International Gmbh	Organische Verbindungen mit biologischer Wirkung als Thrombinhemmer und ihre Verwendung
DE10301255A1 (de)	2003-01-15	2004-07-29	Cpi Creative Pharma International Gmbh	Organische Verbindungen mit biologischer Wirkung als Thrombinhemmer und ihre Verwendung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3342139A1 (de) *	1983-11-22	1985-05-30	Ciba-Geigy Ag, Basel	Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
DE3438296A1 (de) *	1984-04-18	1985-11-07	Hoechst Ag, 6230 Frankfurt	Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel

1983
- 1983-11-22 DE DE19833342139 patent/DE3342139A1/de not_active Withdrawn
1984
- 1984-11-20 CA CA000468216A patent/CA1239606A/fr not_active Expired
- 1984-11-20 IL IL73570A patent/IL73570A/xx not_active IP Right Cessation
- 1984-11-20 DD DD84269667A patent/DD232498A5/de not_active IP Right Cessation
- 1984-11-20 DE DE1997175096 patent/DE19775096I2/de active Active
- 1984-11-20 AT AT84114038T patent/ATE56021T1/de active
- 1984-11-20 EP EP84114038A patent/EP0142860B1/fr not_active Expired - Lifetime
- 1984-11-20 DE DE8484114038T patent/DE3483085D1/de not_active Expired - Lifetime
- 1984-11-21 JP JP59244681A patent/JP2551551B2/ja not_active Expired - Lifetime
- 1984-11-21 IE IE2979/84A patent/IE57885B1/en not_active IP Right Cessation
- 1984-11-21 US US06/673,952 patent/US4654302A/en not_active Expired - Lifetime
- 1984-11-21 NZ NZ210275A patent/NZ210275A/xx unknown
- 1984-11-21 ZA ZA849068A patent/ZA849068B/xx unknown
- 1984-11-21 DK DK552684A patent/DK165696C/da not_active IP Right Cessation
- 1984-11-21 AU AU35759/84A patent/AU578050B2/en not_active Expired
1986
- 1986-11-13 US US06/929,710 patent/US4745177A/en not_active Expired - Lifetime
- 1986-11-20 PH PH31466A patent/PH23831A/en unknown
1988
- 1988-01-19 US US07/145,023 patent/US4801576A/en not_active Expired - Lifetime
1992
- 1992-06-25 MX MX9203370A patent/MX9203370A/es unknown
1993
- 1993-11-04 HK HK1212/93A patent/HK121293A/xx not_active IP Right Cessation
1995
- 1995-10-20 CY CY173795A patent/CY1737A/xx unknown
1997
- 1997-12-19 NL NL970045C patent/NL970045I2/nl unknown
- 1997-12-31 LU LU90192C patent/LU90192I2/fr unknown

Also Published As

Publication number	Publication date
EP0142860A2 (fr)	1985-05-29
JPS60136597A (ja)	1985-07-20
DK552684A (da)	1985-05-23
JP2551551B2 (ja)	1996-11-06
IL73570A (en)	1988-05-31
IL73570A0 (en)	1985-02-28
ZA849068B (en)	1985-07-31
DK552684D0 (da)	1984-11-21
DK165696B (da)	1993-01-04
NL970045I2 (nl)	1998-08-03
DE3342139A1 (de)	1985-05-30
CA1239606A (fr)	1988-07-26
CY1737A (en)	1995-10-20
US4801576A (en)	1989-01-31
AU578050B2 (en)	1988-10-13
LU90192I2 (fr)	1998-03-02
DD232498A5 (de)	1986-01-29
MX9203370A (es)	1992-09-01
EP0142860B1 (fr)	1990-08-29
HK121293A (en)	1993-11-12
NZ210275A (en)	1988-08-30
ATE56021T1 (de)	1990-09-15
IE842979L (en)	1985-05-22
AU3575984A (en)	1985-05-30
DE19775096I2 (de)	2002-07-04
DE3483085D1 (de)	1990-10-04
IE57885B1 (en)	1993-05-05
US4745177A (en)	1988-05-17
EP0142860A3 (en)	1987-03-11
PH23831A (en)	1989-11-23
NL970045I1 (nl)	1998-03-02
US4654302A (en)	1987-03-31

Legal Events

Date	Code	Title	Description
1998-04-06	CTFF	Application for supplementary protection certificate (spc) filed	Free format text: CA 1997 00045, 971120
2004-12-06	PUP	Patent expired

Publication	Publication Date	Title
DK552684D0 (da)	1984-11-21	Desulfatohirudiner samt deres fremstilling og anvendelse
DK609984D0 (da)	1984-12-19	Salte af l-carnitin og alkanoyl-l-carnitiner, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
DK83388D0 (da)	1988-02-18	Farmaceutisk middel indeholdende den insulin-lignende vaekstfaktor ii (igf-ii) til topisk anvendelse til saarheling
DK0654078T3 (da)	2004-01-26	Thrombinblodfraktion til anvendelse i en medicinsk procedure
DK165988C (da)	1993-07-26	Modificerede egliner b og c, deres anvendelse som proteaseinhibitorer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende de modificerede egliner b og c
DK12183D0 (da)	1983-01-13	Vandig, isoton oploesning samt fremgangsmade til rensning og desinfektion af bloede kontaktlinser
NO871361D0 (no)	1987-04-01	Fremgangsmaate for redusering av fluidtap i sementsammensetninger som kan inneholde vesentlige saltkonsentrasjoner.
DK0558529T3 (da)	1996-06-03	Farmaceutisk præparat til behandling af forlænget koagulationstid
DK167187D0 (da)	1987-04-01	Carbostyrilderivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
DK160981C (da)	1991-10-28	Arylsulfonylurinstof-derivater, fremgangsmaade til fremstilling deraf, anvendelse af disse som terapeutisk og antineoplastisk middel samt farmaceutiske midler indeholdende saadanne derivater
DK249386D0 (da)	1986-05-28	Benzoyl-urinstofderivater, fremgangsmaade til fremstilling af saadanne forbindelser og anvendelse af disse som insecticider
DK93685A (da)	1985-09-02	Benzisoselenazolthioner, fremgangsmaade til fremstilling af disse forbindelser og farmaceutiske praeparater indeholdende disse forbindelser
DK434884D0 (da)	1984-09-12	Benzothiopen-derivater til anvendelse som midler mod astma samt farmaceutiske formuleringer indeholdende saadanne derivater
DK159420C (da)	1991-03-11	N-(piperidinyl-alkyl)-carboxamider og salte deraf, farmaceutiske praeparater indeholdende disse forbindelser samt anvendelsen af forbindelserne til fremstilling af antipsykotiske farmaceutiske praeparater
NO921382D0 (no)	1992-04-08	Amidinofenylalaninderivater, samt fremstilling, anvendelse og preparater inneholdende forbindelsene
DK369280A (da)	1981-03-02	N-phenylpropylsubstituerede azoler samt fremgangsmaade til fremstilling af saadanne forbindelser og anvendelse af disse i fungicide midler
DK160296C (da)	1991-07-29	Acylerede naphthylaminer og salte og metalkomplekser deraf, middel indeholdende disse forbindelser samt deres anvendelse som plantefungicider
DK453184A (da)	1985-03-23	1-azolyl-substituerede oximethere, fremgangsmaade til fremstilling deraf og deres anvendelse som fungicider
DK4287A (da)	1987-07-08	Polyfluoralkylthiomethyl-forbindelser, fremgangsmaade til fremstilling deraf og anvendelse af saadanneforbindelser som overfladeaktive midler
DK585984D0 (da)	1984-12-07	1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan og salte deraf til anvendelse ved bekaempelse af sygdomme samt fremgangsmaade til fremstilling af saadanne nonanderivater
NO830966L (no)	1983-09-20	Sulfonylurinstoffer, fremgangsmaate til deres fremstilling, farmasoeytiske preparater paa basis av disse forbindelser, og deres anvendelse
DK630088A (da)	1989-05-14	Azelastinembonat, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater med indhold af denne forbindelse som aktivt middel
DK319384D0 (da)	1984-06-29	1-0-alkyl-3-amino-propan-1,2-diol-2-0-phospholipider, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse
DK507684D0 (da)	1984-10-24	Thiadiazinderivater, fremgangsmaader til deres fremstilling og farmaceutiske midler indeholdende disse thiadiazinderivater
ATE175349T1 (de)	1999-01-15	Verwendung von etofibrat und pharmazeutische zusammensetzungen, enthaltend etofibrat, zur behandlung der diabetischen angio- und retinopathie